{"title":"Chondrocalcinosis and Osteoarthritis: A Literature Review.","authors":"Stacey Ying Guo, Cassandra A Lee, Barton L Wise","doi":"10.5152/eurjrheum.2023.21093","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to review the literature on associations between chondrocalcinosis (CC) and osteoarthritis (OA) and to examine the role of colchicine, previously established as effective for calcium pyrophosphate deposition disease, in the treatment of OA.</p><p><strong>Methods: </strong>A literature search for mechanistic and clinical studies published between 1990 and 2021 listed in PubMed was performed and studies were included if they examined the associations between OA and CC or colchicine using relevant search terms.</p><p><strong>Results: </strong>Published evidence suggests significant radiographic and mechanistic associations between knee OA and knee CC, but there are only a limited number of studies demonstrating associations between OA and CC in the hips, hands, and ankles. We examined three studies testing the efficacy of colchicine on treatment of pain in OA and found insufficient evidence to definitively establish that colchicine is effective to ameliorate symptoms of OA, although differences in study methodologies and inclusion criteria may explain inconsistent study findings.</p><p><strong>Conclusion: </strong>An association between CC and OA is supported at the knee joint in both radiographic and in-vitro studies, but is less definite when the relationship is evaluated at other joints, including at the hips, hands, and ankles. Further research is required to ascertain whether CC modifies symptoms in patients with osteoarthritis or is associated with OA progression. It may be worthwhile to further evaluate colchicine or other agents for potential symptom modifying roles in OA or in OA with CC.</p>","PeriodicalId":12066,"journal":{"name":"European journal of rheumatology","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2023-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5152/eurjrheum.2023.21093","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The objective of this study was to review the literature on associations between chondrocalcinosis (CC) and osteoarthritis (OA) and to examine the role of colchicine, previously established as effective for calcium pyrophosphate deposition disease, in the treatment of OA.
Methods: A literature search for mechanistic and clinical studies published between 1990 and 2021 listed in PubMed was performed and studies were included if they examined the associations between OA and CC or colchicine using relevant search terms.
Results: Published evidence suggests significant radiographic and mechanistic associations between knee OA and knee CC, but there are only a limited number of studies demonstrating associations between OA and CC in the hips, hands, and ankles. We examined three studies testing the efficacy of colchicine on treatment of pain in OA and found insufficient evidence to definitively establish that colchicine is effective to ameliorate symptoms of OA, although differences in study methodologies and inclusion criteria may explain inconsistent study findings.
Conclusion: An association between CC and OA is supported at the knee joint in both radiographic and in-vitro studies, but is less definite when the relationship is evaluated at other joints, including at the hips, hands, and ankles. Further research is required to ascertain whether CC modifies symptoms in patients with osteoarthritis or is associated with OA progression. It may be worthwhile to further evaluate colchicine or other agents for potential symptom modifying roles in OA or in OA with CC.
研究目的本研究旨在回顾有关软骨钙化症(CC)与骨关节炎(OA)之间关系的文献,并探讨秋水仙碱(以前曾被证实对焦磷酸钙沉积症有效)在治疗OA中的作用:对PubMed上1990年至2021年间发表的机理和临床研究进行文献检索,使用相关检索词研究OA与CC或秋水仙碱之间关系的研究均被纳入:已发表的证据表明,膝关节 OA 和膝关节 CC 之间存在明显的放射学和机理关联,但只有少数研究表明,髋关节、手部和脚踝的 OA 和 CC 之间存在关联。我们研究了三项测试秋水仙碱治疗 OA 疼痛疗效的研究,发现没有足够的证据可以明确秋水仙碱对改善 OA 症状有效,尽管研究方法和纳入标准的差异可能是研究结果不一致的原因:结论:CC与OA之间的关系在膝关节的影像学和体外研究中都得到了支持,但在评估其他关节(包括髋关节、手部和脚踝)的关系时则不那么明确。要确定CC是否会改变骨关节炎患者的症状或与OA进展相关,还需要进一步研究。也许值得进一步评估秋水仙碱或其他药物对OA或伴有CC的OA的潜在症状调节作用。